Nuveen Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$27.2M Buy
1,304,391
+165,249
+15% +$3.45M 0.01% 979
2024
Q3
$22.6M Buy
1,139,142
+308,586
+37% +$6.13M 0.01% 1098
2024
Q2
$12.9M Buy
830,556
+260,037
+46% +$4.03M ﹤0.01% 1422
2024
Q1
$9.09M Buy
570,519
+301,807
+112% +$4.81M ﹤0.01% 1653
2023
Q4
$4.52M Buy
268,712
+4,877
+2% +$82K ﹤0.01% 2038
2023
Q3
$3.08M Buy
263,835
+4,631
+2% +$54.1K ﹤0.01% 2112
2023
Q2
$3.48M Sell
259,204
-5,367
-2% -$72.1K ﹤0.01% 2082
2023
Q1
$4.39M Sell
264,571
-661,306
-71% -$11M ﹤0.01% 1969
2022
Q4
$17.2M Sell
925,877
-457,912
-33% -$8.52M 0.01% 1150
2022
Q3
$17.8M Sell
1,383,789
-65,968
-5% -$846K 0.01% 1098
2022
Q2
$10.2M Buy
1,449,757
+751,576
+108% +$5.27M ﹤0.01% 1498
2022
Q1
$5.48M Sell
698,181
-30,753
-4% -$241K ﹤0.01% 2013
2021
Q4
$4.68M Sell
728,934
-73,349
-9% -$471K ﹤0.01% 2163
2021
Q3
$4.05M Sell
802,283
-108,682
-12% -$549K ﹤0.01% 2326
2021
Q2
$5.24M Buy
910,965
+33,484
+4% +$193K ﹤0.01% 2221
2021
Q1
$4.05M Sell
877,481
-39,348
-4% -$181K ﹤0.01% 2266
2020
Q4
$3.06M Buy
916,829
+533,282
+139% +$1.78M ﹤0.01% 2295
2020
Q3
$1.14M Buy
383,547
+1,910
+0.5% +$5.67K ﹤0.01% 2631
2020
Q2
$1.76M Sell
381,637
-17,781
-4% -$82.1K ﹤0.01% 2392
2020
Q1
$1.54M Sell
399,418
-1,750,115
-81% -$6.74M ﹤0.01% 2315
2019
Q4
$8.06M Buy
2,149,533
+1,748,591
+436% +$6.56M ﹤0.01% 1720
2019
Q3
$2.13M Buy
400,942
+6,377
+2% +$33.9K ﹤0.01% 2368
2019
Q2
$1.52M Buy
+394,565
New +$1.52M ﹤0.01% 2562